Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies.
Remuzzi
G
G
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
D000818:Animals; D003524:Cyclosporins / Q000633:toxicity; D004317:Doxorubicin / Q000633:toxicity; D015777:Eicosanoids / Q000378:metabolism*; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D009401:Nephrosis / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D010972:Platelet Activating Factor / Q000378:metabolism*; D011691:Puromycin / Q000633:toxicity; D011817:Rabbits; D051381:Rats
D003524:Cyclosporins; D015777:Eicosanoids; D010972:Platelet Activating Factor; D011691:Puromycin; D004317:Doxorubicin